UCB S.A. (UCBJY.US) Latest Stock News - Major News Analysis - Longbridge

Quote List Quote List

Event Tracking

Nov25

UBS and Barclays Maintain Buy Rating on UCB S.A.

03:46

Nov17

Barclays Analyst Reiterates Buy Rating on UCB S.A.

06:56

Nov3

UCB S.A. 's KYGEVVI Receives FDA Approval and Plans to Launch in the US

21:00

Oct31

UCB S.A. to Present Bimekizumab Clinical Trial Results for Severe Axillary Odor at SHSA 2025

17:03

Oct29

UCB S.A. to Present New Clinical Data on MG Therapies at 2025 AANEM Annual Meeting

06:01

Oct14

Barclays Reiterates Buy Rating on UCB SA Stock

05:26

Schedules & Filings

Schedules

Filings

Jul31

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 2.041 B, Net Income 278.01 M, EPS 0.714

May14

Distribution Plan(EST)

Cash dividend 0.7904 USD

Apr28

Distribution Plan(EST)

Cash dividend 0.7904 USD

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More